The CDC response to measles deaths in Pennsylvania is raising new concerns among public health experts who fear that political pressure could weaken confidence in federal health data as measles cases continue to rise across the United States.
The country is experiencing its worst measles resurgence in decades, while vaccination rates continue to decline. At the same time, seasonal and recurring threats from influenza, COVID-19 and RSV remain important public health concerns.
Against that backdrop, the handling of two Pennsylvania deaths attributed by state officials to measles has become a test of confidence in the Centers for Disease Control and Prevention. Health and Human Services Secretary Robert F. Kennedy Jr. publicly questioned the deaths, while the CDC subsequently removed the cases from its website.
Dr. Demetre Daskalakis, who resigned last year as director of the CDC’s National Center for Immunization and Respiratory Diseases, described the development as a serious warning sign.
“Red flag. Red alert,” Daskalakis said.
His concern is not limited to the two deaths themselves. Public health experts say the dispute raises broader questions about how states and the federal government will work together to identify, classify and communicate infectious-disease threats.
That relationship is fundamental to the U.S. public health system. State health departments investigate illnesses and deaths within their jurisdictions, while federal agencies aggregate information and use national data to help doctors, health officials and the public understand how diseases are spreading.
When disagreements emerge over basic disease counts or causes of death, experts say, the consequences can extend beyond a single case.
Why the CDC Response to Measles Deaths Has Raised Alarm
Typically, when a person dies from measles, the state where the death occurs determines the cause and communicates the information to federal health authorities. The CDC generally relies on those state determinations when compiling national disease information.
The Pennsylvania cases have disrupted that familiar process.
Kennedy’s decision to publicly challenge the state’s determination, followed by the CDC’s removal of the deaths from its website, has generated concern among former federal officials and independent public health specialists.
Daskalakis argues that questioning a state’s determination of a death in this way could undermine one of the basic mechanisms used to coordinate public health action.
“When they raise doubt on the adjudication that a state may have made around a death, that is highly problematic,” Daskalakis said. “This is dangerous.”
The issue is particularly sensitive because measles is highly contagious and outbreaks depend heavily on vaccination coverage. CDC measles data and research provide national information used to track cases and understand the progression of outbreaks.
Anne Zink, a senior fellow at the Yale School of Public Health and former Alaska chief medical officer, said the dispute illustrates a deeper deterioration in trust between state and federal health authorities.
“What we have been seeing, that got amplified even more with these measles cases, is a breakdown in the coordination and trust between states and the federal government,” Zink said.
She described the relationship between state and federal health agencies as essential to protecting public health.
The concern extends beyond measles. If state officials, doctors and the public begin questioning whether federal disease data accurately reflects what is happening on the ground, experts say the problem could affect responses to other infectious diseases.
Georges Benjamin, executive director of the American Public Health Association, said national health information must remain grounded in reliable evidence.
“We need to have good solid evidence-based national data,” Benjamin said. “And I’m obviously concerned that it will happen again for other infectious diseases.”
He specifically pointed to influenza and COVID-19 as examples of diseases for which trustworthy national data can influence how people and healthcare professionals respond.
“If it happens with flu and with COVID, the question is: Who can we rely on for the data on a national level,” Benjamin said. “More people will get sick and more people because they won’t know what to do.”
The issue therefore goes beyond an argument over two deaths. Public health officials depend on consistent data to recognize outbreaks, communicate risks and determine where additional vaccination or other interventions may be needed.
New CDC Leadership Faces Pressure to Restore Trust
The controversy comes at a difficult moment for the CDC itself.
Dr. Erica Schwartz recently became CDC director after a turbulent period that included major staff reductions, internal disruption and concerns about the agency’s morale and effectiveness. Her appointment created expectations among some public health professionals that new leadership could restore confidence in the institution.
Schwartz is a physician and attorney with public health experience. Critics now question whether the agency under her leadership will be willing or able to resist political pressure when scientific assessments conflict with the administration’s position.
Daskalakis described the current situation in unusually stark terms.
“We are seeing a pretty compromised CDC and a director who is at best facilitating non-scientific behavior and at worst colluding with non-scientific behavior,” he said.
Debra Houry, who resigned as the CDC’s chief medical officer at the same time as Daskalakis, has also criticized the agency’s focus.
Rather than concentrating on disputes over disease counts, Houry said, CDC leadership should be addressing the continuing measles outbreak and the decline in childhood vaccination rates.
Her concern is especially immediate as children return to school. Kindergarten vaccination rates are an important part of maintaining population-level protection against measles, and declining immunization coverage can leave communities more vulnerable to outbreaks.
Houry said she had not heard Schwartz publicly emphasize the importance of increasing vaccination among kindergarteners despite the declining rates.
The CDC’s institutional role makes that public communication particularly important. Federal health officials do not simply collect statistics. They also provide recommendations, coordinate with state health departments and communicate risks to physicians and the public.
When confidence in those functions weakens, state and local authorities may face greater difficulty persuading people to act on federal health recommendations.
The agency’s credibility also matters during rapidly developing outbreaks, when public health officials need to communicate quickly. If people begin treating federal health statistics as politically influenced rather than scientifically grounded, even accurate information can become harder to trust.
Kennedy has a long history of questioning vaccines, making the Pennsylvania dispute especially contentious among public health professionals who are already concerned about declining immunization rates.
At the same time, the CDC faces the challenge of rebuilding confidence after a period that has left many employees and former officials concerned about the agency’s standing.
Anne Zink’s public health profile details her previous leadership in Alaska and her work at the Yale School of Public Health, providing context for her concerns about cooperation between state and federal health authorities.
Why Reliable National Health Data Matters Beyond Measles
The dispute over the Pennsylvania deaths comes as the United States confronts several recurring infectious-disease threats.
Measles remains the most immediate concern highlighted by the controversy because vaccination rates have fallen while cases have increased. However, influenza, COVID-19 and RSV continue to require surveillance and public communication as well.
For each of these diseases, national data helps officials determine where transmission is occurring, how severe outbreaks are becoming and which populations may be most vulnerable.
State health departments remain central to that process because they investigate individual cases and deaths. Federal agencies then provide national coordination and broader analysis.
That system depends heavily on trust.
If state officials believe federal agencies may alter or challenge information for political reasons, they may become less confident in sharing sensitive findings. If doctors question federal statistics, they may have more difficulty explaining disease risks to patients. And if the public loses confidence in national health information, vaccination and other preventive measures can become harder to promote.
Benjamin warned that uncertainty over who can be trusted for national health information could ultimately have direct consequences for people’s health.
The concerns are also relevant to the CDC’s handling of future outbreaks. Disease surveillance is most useful when data can be compared consistently over time. Changes in how cases or deaths are classified can make it more difficult to determine whether an apparent increase or decrease reflects a genuine epidemiological change or a change in reporting.
That is why the Pennsylvania measles dispute has become larger than a disagreement over two individual deaths.
The episode is testing the relationship between federal and state health agencies at a time when the country needs those institutions to coordinate closely. It is also testing whether the CDC can maintain its credibility while operating under a politically contentious administration.
The American Public Health Association continues to emphasize the importance of evidence-based public health policy and reliable national health information. Georges Benjamin and the American Public Health Association provide additional context on the role of national public health leadership.
Neither the CDC nor the Department of Health and Human Services responded to repeated requests for comment about the Pennsylvania measles deaths and the concerns raised by former federal officials.
For public health professionals watching the measles resurgence, the immediate concern is not only how many cases are being recorded. It is whether the institutions responsible for tracking those cases can continue to provide information that states, doctors and the public consider dependable.
<a href=”https://www.npr.org/2026/08/27/nx-s1-5945759/political-bickering-follows-two-deaths-related-to-measles-in-pennsylvania” target=”_blank” rel=”noopener noreferrer”>NPR’s reporting on the Pennsylvania measles dispute</a> documents the controversy surrounding the two deaths and the CDC’s handling of the cases.
